Treatment options in myocarditis and inflammatory cardiomyopathy: Focus on i. v. immunoglobulins

For myocarditis and inflammatory cardiomyopathy, an etiologically driven treatment is today the best option beyond heart failure therapy. Prerequisites for this are noninvasive and invasive biomarkers including endomyocardial biopsy and polymerase chain reaction on cardiotropic agents. Imaging by Do...

Descripción completa

Detalles Bibliográficos
Autores principales: Maisch, B., Alter, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2018
Materias:
Main Topic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096625/
https://www.ncbi.nlm.nih.gov/pubmed/29947834
http://dx.doi.org/10.1007/s00059-018-4719-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096625/
https://www.ncbi.nlm.nih.gov/pubmed/29947834
http://dx.doi.org/10.1007/s00059-018-4719-x

Ejemplares similares